A Warsaw seed-stage venture firm backing European technologies in energy, industry and resilience, generally investing €0.5M–€2M initially.
Founded —
Type Venture capital 1 Montis VC fund (2026) 2026-03-20 2026-03-20 €50M 2026 first close: EUR50m reported on March 20, 2026; a firm-reposted partner statement gives EUR51.5m first close and EUR100m target. Exact first-close precision remains unresolved. No verified final close; structural amount remains unknown.
SHOW MORE
— — – — — — – — — — – — — — – — — — – — — — – — — — – —
SHOW MORE
No co-investors on record yet.
team@apexlogos.ai · 12 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size and investment stages
| Vehicle / metric | Finding | Evidence and date |
|---|---|---|
| New Montis VC fund, 2026 | €50m **first close**, not verified final close. Intended 20–25 pre-seed/seed investments; half reserved for follow-ons. EIF via REPowerEU, PFR Ventures (€10m), private investors and family offices reported as LPs. | [The Next Web](https://thenextweb.com/news/montis-vc-50m-fund-energy-industrial-tech-europe ), 2026-03-20; [Puls Biznesu](https://www.pb.pl/montis-ma-50-mln-eur-na-start-upy-stawia-na-technologie-wzmacniajace-gospodarke-europy-1258212 ), 2026-03-20; [firm LinkedIn](https://www.linkedin.com/company/montisvc/ ), undated relative-time posts, directly read. |
| Target / precision uncertainty | Firm LinkedIn announcement describes €50m first close. An embedded Bart Dujczynski post says €51.5m first close and €100m target. Reporting above rounds to €50m and does not specify final target. **€100m is a reported target, not committed capital; €51.5m precision needs an authoritative dated release.** | [Firm LinkedIn page](https://www.linkedin.com/company/montisvc/ ), accessed 2026-10-06; source displays relative rather than calendar dates. |
| Montis Capital predecessor | Official site lists €35m **target balance-sheet size**, €18.6m Polish Development Fund backing, €1.5–5m tickets and Series A onward. These are predecessor metrics, not Montis VC’s current fund/AUM. | [Montis Capital](https://montiscap.com/ ), undated. |
| Current checks and stages | Pre-seed and seed; €0.5–2m initial ticket, up to €5m **including follow-ons**; CEE roots and European reach. Energy, industry, resilience. | [Montis VC official website](https://montis.vc/ ), undated. |
No later final close was verified in the sources checked. Do not treat €30m historically deployed by the team, €35m predecessor target, €50m new fund close or €100m new fund target as interchangeable AUM. A third-party directory, [Private Equity List](https://privateequitylist.com/investors/montis-vc ), claims $200m AUM, North America focus and $10–50m tickets; these contradict official strategy and are **not accepted**. [Venture Capital Archive](https://venturecapitalarchive.com/venture-funds/montis-vc-montis-vc ) describes an Amsterdam SaaS firm established in 2022, also inconsistent and not used.
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| Montis VC fund (2026) | EUR 50000000 | 2026-03-20 | SHOW MORE
team@apexlogos.ai · 12 hours ago
Match research 2026-10-06 / MontisVC / sha256:563594b919394c3ec16f3cb347671acfd3d68dbdbae386f7a436cd71f858705c / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
- **Pstryk**: €7m **Series A**, participated by Montis VC alongside lead Future Energy Ventures, Axpo and existing investors. [Transaction counsel](https://www.kondrackicelej.pl/pl-blog/kondracki-celej-future-energy-ventures-inwestycja-pstryk ), undated, confirms attribution; [lead investor partner’s announcement](https://www.linkedin.com/posts/moritz-jungmann_7m-series-a-for-pstryk-to-scale-dynamic-activity-7487442933777002496-sM1s ) describes dynamic electricity prices and household optimization for solar, batteries and EVs. **Energy software/energy transition adjacent; deep-tech status not established.** Public indices place announcement in July 2026 but the precise event date is not primary-verified. Series A transaction shows actual activity beyond a strict seed label; do not rewrite current mandate based on this single transaction.
- **Volteum**: **€3.25m round**, firm and [company announcement](https://www.linkedin.com/posts/volteum_were-excited-to-share-that-volteum-has-raised-activity-7493586507140804610-katU ) name Montis VC; company says co-led with Movens Capital. [Official history](https://www.volteum.io/about ) dates closing to **July 2026**. Fleet intelligence software using OEM APIs; **no verified hardware/scientific breakthrough supporting strict deep-tech classification**. Firm’s LinkedIn calls it its second investment of the year. Exact round stage and Montis cheque are undisclosed. Relative LinkedIn announcement time should not replace official closing month.
## Neurotech
**No verified neurotech investment found in the sources checked.** Checked current official strategy, predecessor portfolio, named Adex investments and targeted searches for Montis VC/Capital with neuro, brain and neuroscience. Neither Biotts’s drug-delivery technology nor Proteon’s bacteriophage animal-health products establish neural interfaces, brain sensing/stimulation or neuroscience-specific therapeutics. No partner’s prior-firm neuro investment was attributed to Montis. This is a bounded search result, not proof that the firm has never invested in neurotech.
## Concrete review notes for a later Adex agent
1. Preserve exact firm ID `MontisVC`. Check legal relationship to Montis Capital before changing historical investment attribution; existing Adex entries mostly lack chronology and source-specific amounts.
2. Fund-size candidate: €50m first close announced 2026-03-20, new Montis VC fund. Seek dated firm/EIF/PFR release for €51.5m precision, €100m target and any later final close. Current official checks/stages can be cited separately.
3. Investigate Volteum, missing from baseline, and enrich Pstryk only after verifying calendar date and stage. Save rounds’ total sizes separately from investor cheque amounts.
4. Reconcile Biotts dates and Fresh Inset round chronology before inserting dates/amounts. Firm website testimonials alone do not identify the investing legal vehicle.
5. Obtain a specific NFX Signal profile if available; the retrieved directory filter provides no usable mandate evidence. No neurotech company should be added on present evidence.
All links above were accessed 2026-10-06. Publication dates are supplied where directly available; undated, indexed-only and conflicting evidence is explicitly marked. Research files only were changed; no database or Adex mutations were made. SHOW MORE
team@apexlogos.ai · 12 hours ago
Match research 2026-10-06 / MontisVC / sha256:563594b919394c3ec16f3cb347671acfd3d68dbdbae386f7a436cd71f858705c / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Montis VC
- Exact Adex ID: `MontisVC`
- Adex webpage: https://adex.page/firms/MontisVC
- Official website: https://montis.vc/
- Research date and all source access dates: **2026-10-06**
- Status: completed research handoff; **no Adex update performed**.
Montis VC is a Warsaw fund investing in European energy, industry and resilience at pre-seed/seed. Latest verified public fund announcement found is a **€50m first close in March 2026**. Crucial attribution issue: the team’s earlier **Montis Capital** portfolio is displayed as track record and appears in Adex as MontisVC investments; historical transactions should not automatically be attributed to the new 2026 fund.
## Starting evidence: Adex MCP and NFX Signal
Read first: `data/research/_sources/MontisVC.adex.json`, a read-only Search result retrieved 2026-10-06 from `http://localhost:3000/mcp` , exact returned record `MontisVC` (investor ID 6080), with Match label. Adex describes a Warsaw seed investor in European energy, industry and resilience and €0.5–2m initial checks. Check-size fields are null, fund size absent. Baseline source is the firm website, researched 2026-09-14. Roles include Łukasz Dziekoński, Wojtek Szwankowski and Michał Gawęda as partners. It lists Talkin' Things, Skriware, PlumResearch, Biotts, Proteon Pharmaceuticals, Fresh Inset, Plenti, PORT, Autofixer, buycycle and Pstryk; amounts and dates are all absent. These are starting claims, not independent verification.
No Signal URL is present in Adex. Searched `site.signal.nfx.com "Montis"`, investor-specific searches and Dziekonski/Gaweda/Szwankowski names. [NFX Signal marketplace seed list](https://signal.nfx.com/investor-lists/top-marketplaces-seed-investors ) was directly opened and includes Montis VC among firm filter options; [SaaS seed list](https://signal.nfx.com/investor-lists/top-saas-seed-investors ) also appears in search results. **No firm-specific or team-specific Signal profile, check-size claim or actual relevant investor row was verified.** Inclusion in a global dropdown is not evidence that Montis follows the list’s sector/stage. Undated; accessed 2026-10-06.
## Fund size and investment stages
| Vehicle / metric | Finding | Evidence and date |
|---|---|---|
| New Montis VC fund, 2026 | €50m **first close**, not verified final close. Intended 20–25 pre-seed/seed investments; half reserved for follow-ons. EIF via REPowerEU, PFR Ventures (€10m), private investors and family offices reported as LPs. | [The Next Web](https://thenextweb.com/news/montis-vc-50m-fund-energy-industrial-tech-europe ), 2026-03-20; [Puls Biznesu](https://www.pb.pl/montis-ma-50-mln-eur-na-start-upy-stawia-na-technologie-wzmacniajace-gospodarke-europy-1258212 ), 2026-03-20; [firm LinkedIn](https://www.linkedin.com/company/montisvc/ ), undated relative-time posts, directly read. |
| Target / precision uncertainty | Firm LinkedIn announcement describes €50m first close. An embedded Bart Dujczynski post says €51.5m first close and €100m target. Reporting above rounds to €50m and does not specify final target. **€100m is a reported target, not committed capital; €51.5m precision needs an authoritative dated release.** | [Firm LinkedIn page](https://www.linkedin.com/company/montisvc/ ), accessed 2026-10-06; source displays relative rather than calendar dates. |
| Montis Capital predecessor | Official site lists €35m **target balance-sheet size**, €18.6m Polish Development Fund backing, €1.5–5m tickets and Series A onward. These are predecessor metrics, not Montis VC’s current fund/AUM. | [Montis Capital](https://montiscap.com/ ), undated. |
| Current checks and stages | Pre-seed and seed; €0.5–2m initial ticket, up to €5m **including follow-ons**; CEE roots and European reach. Energy, industry, resilience. | [Montis VC official website](https://montis.vc/ ), undated. |
No later final close was verified in the sources checked. Do not treat €30m historically deployed by the team, €35m predecessor target, €50m new fund close or €100m new fund target as interchangeable AUM. A third-party directory, [Private Equity List](https://privateequitylist.com/investors/montis-vc ), claims $200m AUM, North America focus and $10–50m tickets; these contradict official strategy and are **not accepted**. [Venture Capital Archive](https://venturecapitalarchive.com/venture-funds/montis-vc-montis-vc ) describes an Amsterdam SaaS firm established in 2022, also inconsistent and not used.
## Previous deep-tech investments and attribution
The strongest verified historical science/hardware investments belong to **Montis Capital**, the predecessor managed by the same team. Include them as predecessor track record unless legal fund continuity can be established. Classification below is researcher interpretation of the described technologies.
| Company | Technology and classification | Investment evidence, amount and date |
|---|---|---|
| **Talkin' Things** | RFID/NFC smart packaging and tag manufacturing; hardware/IoT deep-tech candidate, stronger than ordinary SaaS. | [PFR Ventures report](https://pfrventures.pl/en/document/1138 ) identifies **Montis Capital**, initial April 2019 and follow-on July 2020. [Business Insider Polska](https://businessinsider.com.pl/firmy/strategie/talkin-things-inwestycja-montis-capital-i-pfr-na-15-mln-zlotych/1h2d5sy ), 2019-05-21, reports approximately PLN15m investment with private partners. [Puls Biznesu](https://www.pb.pl/wiara-w-inteligentne-opakowania-985788 ), 2020-03-19, reports PLN14.1m actually paid in 2019 by Montis and co-investors. Approximation/transaction-scope discrepancy; neither is solely Montis’s cheque. |
| **Biotts** | Proprietary transdermal drug carriers/formulations, allowing delivery of medical compounds through skin; biotech deep tech, **not demonstrated neurotech**. | [Company announcement](https://biotts.com/news/biotts-has-acquired-7-mln-pln-from-investors/ ) says Montis Capital invested **over PLN7m** and displays **2020-03-22**. [PFR Startup](https://startup.pfr.pl/artykul/montis-capital-zainwestowal-ponad-7-mln-zl-w-spolke-biotts ), 2020-05-20, reports same investment; [original press-release PDF](https://incredibles.pl/wp-content/uploads/2020/09/Biotech-company-Biotts-acquires-PLN-7-m-from-investors-1.pdf ) is dated **2020-05-22**. Event date is uncertain because publication dates conflict. |
| **Fresh Inset** | Vidre+ delivery of 1-MCP for post-harvest fruit/vegetable preservation: chemistry/packaging technology, science-based food/agtech deep tech. | [Company press office](https://freshinset.com/press-office/revolutionizing-the-food-industry-how-fresh-inset-is-tackling-global-food-waste/ ) explicitly names **Montis Capital** as investor; undated in retrieved page. [Company’s round announcement](https://www.linkedin.com/posts/fresh-inset_polski-startup-fresh-inset-pozyska%C5%82-10-mln-activity-7008381394200465408-iMhC ) reports **PLN10m Series A** including Montis Capital; calendar date not shown. [Company-hosted analyst report](https://freshinset.com/wp-content/uploads/Niezalezny-raport-analityczny-Fresh-Inset-SA-East-Value-Research-GmbH.pdf ), **2026-05-22**, places a Montis-led $2.3m Series A before 2022. Do not assume these amounts describe separate rounds without reconciling chronology. |
| **Proteon Pharmaceuticals** | Bacteriophage products for animal health and reducing antibiotic use; biotech deep tech, **not neural technology**. | [Montis Capital official site](https://montiscap.com/ ) describes technology. [PFR Ventures Q3 2021 summary](https://pfrventures.pl/en/artykul/polish-vc-market-activity-q3-21-summary ) confirms Montis Capital participation in approximately **€21m** financing; [2021 annual market report](https://pfrventures.pl/en/document/1166 ) labels **Series B, €21.5m**. The round amount is total financing, not Montis’s contribution; exact date not verified from primary announcement. |
Other baseline companies require stricter classification. Montis Capital’s official portfolio describes Skriware as educational robotics and PORT as e-mobility service; these are **hardware/industrial-adjacent candidates**, but this research did not establish original IP/research depth or investment dates. PlumResearch (audience analytics), Plenti (rental subscriptions), Autofixer (car-parts marketplace) and buycycle should **not automatically be classed deep tech**.
Two current-fund investments found: SHOW MORE
team@apexlogos.ai · 23 days ago
MATCH 
Volteum
Port